+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Eczema Drug"

Eczema Therapeutics Market 2024-2028 - Product Thumbnail Image

Eczema Therapeutics Market 2024-2028

  • Report
  • April 2024
  • 172 Pages
  • Global
From
Atopic Dermatitis Drugs Market 2024-2028 - Product Thumbnail Image

Atopic Dermatitis Drugs Market 2024-2028

  • Report
  • May 2024
  • 175 Pages
  • Global
From
Atopic Dermatitis Drugs Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Atopic Dermatitis Drugs Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 143 Pages
  • Global
From
Atopic Dermatitis (AD): Epidemiology Forecast to 2033 - Product Thumbnail Image

Atopic Dermatitis (AD): Epidemiology Forecast to 2033

  • Report
  • December 2024
  • 34 Pages
  • Global
From
From
From
From
United Arab Emirates Eczema Therapeutics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

United Arab Emirates Eczema Therapeutics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • United Arab Emirates United Arab Emirates
From
From
From
From
From
From
From
From
From
Loading Indicator

The Eczema Drug market is a subset of the Dermatological Drugs market, which includes medications used to treat skin conditions. Eczema drugs are used to treat the symptoms of eczema, a chronic skin condition characterized by red, itchy, and inflamed skin. These drugs are typically topical creams, ointments, and lotions, and may contain corticosteroids, calcineurin inhibitors, and other active ingredients. In addition to treating the symptoms of eczema, these drugs may also help to reduce the risk of infection and improve the overall quality of life for those affected by the condition. Some companies in the Eczema Drug market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Mylan. Show Less Read more